A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells. (Q51785972)
Jump to navigation
Jump to search
scientific article published in November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells. |
scientific article published in November 2008 |
Statements
A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells (English)
Julia Stieglmaier
Michael Schwemmlein
Michael Schwenkert
Heiko Singer
Kristin Mentz
Matthias Peipp
Peter Lang
Fuat Oduncu
Bernhard Stockmeyer
1 November 2008